M. Paravicini (Milan, Italy), A. Rossi (Bergamo, Italy)
Meloxicam associated eosinophilic pneumonia
A. Karakatsani, A. Chroneou, N. G. Koulouris, J. Jordanoglou (Athens, Greece)
|  |
Bronchiolitis obliterans organizing pneumonia (BOOP): clinical features in a series of 12 patients
M. Sobiecka, J. Kus, S. Wesolowski, I. Bestry (Warsaw, Poland)
| |
Allergic bronchopulmonary aspergillosis (ABPA) by Aspergillus flavus
M. A. Battista, F. Taglietti, F. Brandimarte, P. Carfagna, C. Brandimarte (Rome, Italy)
| |
The role of familial Mediterranean fever in the ethiology of pleural effusions
F. Ozseker, A. Baran, O. Celik, A. Mihmanli, S. Aslan, E. Akkaya (Istanbul, Turkey)
| |
Familial case of cryptogenic fibrosing alveolitis in two siblings
M. G. Koroleva, L. N. Novikova, O. P. Baranova, M. M. Ilkovich (Saint-Petersburg, Russia)
| |
Langerhans' cell histiocytosis: clinical and diagnostic features and response to therapy
J. Fichter, G. Goetz, C. Doberauer, B. Sanner (Osnabrueck, Gelsenkirchen, Herne, Germany)
| |
Tracheobronchopathia osteochondroplastica
G. Celik, O. Kumbasar, F. Ulger, M. Varli, C. Atasoy, D. Alper (Ankara, Turkey)
| |
Ten-years follow-up of slowly progressive pulmonary lymphangioleiomyomatosis (PLAM)
O. P. Baranova, M. M. Ilkovitch, L. N. Novikova, I. V. Dvorakovskaya, E. M. Dembo-Smeathon, V. I. Amosov (Saint-Petersburg, Russia)
| |
DLCO change in systemic sclerosis patients after prostaglandin E1 infusion: preliminary data
B. Barbara, S. Centanni, F. Di Marco, M. Massarotti, C. Regorda, P. Carlucci, B. Marasini (Milan, Italy)
| |
Leading pulmonary symptoms in an infant with Niemann-Pick disease
G. Baktai, E. Peterffy, E. Szekely, L. Tiszlavicz, B. Nagy, A. Laszlo (Budapest, Szeged, Debrecen, Hungary)
| |
Relapsing polychondritis associated diffuse interstitial lung disease
F. Goncalves, A. Martins, A. Paiva, A. Reis (Porto, Portugal)
| |
Pulmonary alveolar microlithiasis (PAM)
V. N. Adamovitch, V. I. Braude, E. I. Chmidt (Moscow, Russia)
| |
Whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP): long-term lung function follow-up
I. S. A. Cerveri, G. Rodi, M. C. Zoia, P. Pochetti, D. Fiorenza, S. Colato, A. Corsico, M. Luisetti (Pavia, Italy)
| |
The incidence of bronchiolitis obliterans organizing pneumonia syndrome after radiation therapy for breast cancer
S. Morita, S. Miwa, K. Tsukamoto, R. Tamura, T. Suda, K. Chida, H. Nakamura (Fujieda, Hamamatsu, Japan)
| |
A case report: microscopic polyanjiitis and lung involvement
B. E. Gulbay, G. Celik, O. O. Ozdemir, M. Gulbay, D. Alper (Ankara, Turkey)
| |
Efficacy of aerosolized granulocyte-macrophage colony stimulating factor (GM-CSF) in a Japanese female patient with pulmonary alveolar proteinosis (PAP)
O. Ishimoto, R. Tazawa, M. Miki, M. Ebina, J. Saito, K. Nakata, T. Nukiwa (Sendai, Miyagi, Tokyo, Japan)
| |
Hydatid disease of the liver complicated with hepatobronchial fistula developing after a chemotherapy for lung cancer
O. K. Aribas, F. Kanat, S. Ceran, G. S. Sunam (Konya, Turkey)
| |
A case of liquid paraffin pneumonia (pulmonary paraffinoma) defined by gaschromatography-mass spectrometry
S. Rizzo, O. Filieri, P. Papa, P. Cremaschi, A. Rossi (Pavia, Italy)
| |
Changes in lung function tests in lung carcinoma patients due to radiotherapy
N. B. Bogdanovic (Belgrade, Yugoslavia)
| |